SEC Form 4 · accession 0001487371-19-000074
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gleeson
Officer — SVP, Corp. Accounts
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 27, 2019 | S | 26,704 | $7.96 | D | 401,565 | D | |
| Common StockF3 | Feb 28, 2019 | S | 18,464 | $7.84 | D | 383,101 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold by the reporting person solely to satisfy certain financial obligations in connection with the reporting person's marital divorce proceedings.
- F2The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $7.94 to $8.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- F3The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $7.75 to $7.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.